Patent for micheliolide compositions to increase muscle mass
Summary
USPTO published patent application US20260091019A1 by Korea Institute of Science and Technology for a pharmaceutical composition containing micheliolide as an active ingredient for increasing muscle mass, improving muscle function, or preventing or treating muscular disease. The application (No. 19302634) was filed August 18, 2025 and published April 2, 2026, listing 12 inventors including Myungsuk Kim and Choong-Gu Lee.
What changed
The USPTO published patent application US20260091019A1 disclosing a composition comprising micheliolide or a pharmaceutically acceptable salt thereof for therapeutic use in increasing muscle mass, improving muscular functions, or preventing/treating muscular diseases. The claimed invention relates to methods of administration to individuals in need, with the micheliolide composition purportedly providing effects including increased muscle strength, increased muscle weight, and increased muscle fiber. The application is classified under CPC codes A61K 31/365, A61K 9/0056, and A61P 21/06.
This document is a patent application publication, which is informational in nature and does not create any compliance obligations or regulatory requirements. Entities reviewing this publication should note this represents a potential future patent blocking similar compositions or methods in the US market. Pharmaceutical companies developing muscle wasting or muscular disease treatments should consider potential freedom-to-operate issues. No action is required unless the entity is actively developing micheliolide-based therapeutics.
Source document (simplified)
COMPOSITION FOR ENHANCING INCREASING MUSCLE MASS, IMPROVING MUSCULAR FUNCTIONS, OR PREVENTING OR TREATING MUSCULAR DISEASE CONTAINING MICHELIOLIDE
Application US20260091019A1 Kind: A1 Apr 02, 2026
Assignee
KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
Inventors
Myungsuk KIM, Choong-Gu LEE, Hye-Young YOUN, Sun hee PARK, Kwang-Hyun CHA, Dae-geun SONG, Young Tae PARK, Jiyeon SI, Song Yi KOO, Hee Ju LEE, Sang Hoon JUNG, Hyejin KO
Abstract
The present invention relates to a composition for increasing muscle mass, improving muscle function, or preventing or treating muscle disease, comprising micheliolide or a pharmaceutically acceptable salt thereof. In addition, the present invention relates to a method for increasing muscle mass, improving muscle function, or preventing or treating muscular disease, comprising administering or taking a composition comprising micheliolide or a pharmaceutically acceptable salt thereof as an active ingredient to an individual in need. The micheliolide of the present invention has the outstanding effect of increasing muscle strength, increasing muscle weight, and increasing muscle fiber.
CPC Classifications
A61K 31/365 A61K 9/0056 A61P 21/06
Filing Date
2025-08-18
Application No.
19302634
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Therapeutics (A61P) publishes new changes.